LU91769I2 - Ditartrate de Vinflunine. - Google Patents
Ditartrate de Vinflunine.Info
- Publication number
- LU91769I2 LU91769I2 LU91769C LU91769C LU91769I2 LU 91769 I2 LU91769 I2 LU 91769I2 LU 91769 C LU91769 C LU 91769C LU 91769 C LU91769 C LU 91769C LU 91769 I2 LU91769 I2 LU 91769I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- vinflunine
- formula
- preparation
- ditartrate
- sbf5
- Prior art date
Links
- NMDYYWFGPIMTKO-HBVLKOHWSA-N vinflunine Chemical compound C([C@@](C1=C(C2=CC=CC=C2N1)C1)(C2=C(OC)C=C3N(C)[C@@H]4[C@@]5(C3=C2)CCN2CC=C[C@]([C@@H]52)([C@H]([C@]4(O)C(=O)OC)OC(C)=O)CC)C(=O)OC)[C@H]2C[C@@H](C(C)(F)F)CN1C2 NMDYYWFGPIMTKO-HBVLKOHWSA-N 0.000 title abstract 2
- 229960000922 vinflunine Drugs 0.000 title abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 abstract 2
- ZEOVXNVKXIPWMS-UHFFFAOYSA-N 2,2-dichloropropane Chemical compound CC(C)(Cl)Cl ZEOVXNVKXIPWMS-UHFFFAOYSA-N 0.000 abstract 1
- 229910021630 Antimony pentafluoride Inorganic materials 0.000 abstract 1
- 229940122803 Vinca alkaloid Drugs 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
- 230000002927 anti-mitotic effect Effects 0.000 abstract 1
- VBVBHWZYQGJZLR-UHFFFAOYSA-I antimony pentafluoride Chemical compound F[Sb](F)(F)(F)F VBVBHWZYQGJZLR-UHFFFAOYSA-I 0.000 abstract 1
- FJBFPHVGVWTDIP-UHFFFAOYSA-N dibromomethane Chemical compound BrCBr FJBFPHVGVWTDIP-UHFFFAOYSA-N 0.000 abstract 1
- 150000004820 halides Chemical class 0.000 abstract 1
- PQIOSYKVBBWRRI-UHFFFAOYSA-N methylphosphonyl difluoride Chemical group CP(F)(F)=O PQIOSYKVBBWRRI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003930 superacid Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9704398A FR2761990B1 (fr) | 1997-04-10 | 1997-04-10 | Derives halogenes antimitotiques d'alcaloides de vinca |
| EP98920607A EP0975640B1 (fr) | 1997-04-10 | 1998-04-10 | Derives halogenes antimitotiques d'alcaloides de vinca |
| EP20030017052 EP1357125A3 (fr) | 1997-04-10 | 1998-04-10 | Procédé de préparation de dérivés halogénés d'alcaloides de vinca |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU91769I2 true LU91769I2 (fr) | 2011-02-22 |
Family
ID=9505731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU91769C LU91769I2 (fr) | 1997-04-10 | 2010-12-22 | Ditartrate de Vinflunine. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6127377A (enExample) |
| EP (3) | EP0975640B1 (enExample) |
| JP (3) | JP4401440B2 (enExample) |
| AT (2) | ATE270297T1 (enExample) |
| AU (1) | AU737549C (enExample) |
| BR (2) | BR9807944B1 (enExample) |
| CA (3) | CA2665949C (enExample) |
| CY (2) | CY1111476T1 (enExample) |
| DE (3) | DE122010000054I1 (enExample) |
| DK (2) | DK1764368T3 (enExample) |
| ES (2) | ES2347878T3 (enExample) |
| FR (2) | FR2761990B1 (enExample) |
| LU (1) | LU91769I2 (enExample) |
| PT (2) | PT1764368E (enExample) |
| WO (1) | WO1998045301A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2761990B1 (fr) * | 1997-04-10 | 1999-06-25 | Pf Medicament | Derives halogenes antimitotiques d'alcaloides de vinca |
| US6890558B2 (en) * | 2002-05-31 | 2005-05-10 | R.P. Scherer Technologies, Inc. | Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment |
| AU2004296191B2 (en) * | 2003-12-04 | 2010-10-28 | Albany Molecular Research, Inc. | Vinca derivatives |
| US7235564B2 (en) * | 2003-12-04 | 2007-06-26 | Amr Technology, Inc. | Vinorelbine derivatives |
| US20110015221A1 (en) * | 2003-12-23 | 2011-01-20 | Pierre Fabre Medicament | Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| FR2863891B1 (fr) * | 2003-12-23 | 2006-03-24 | Pf Medicament | Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation |
| WO2006122408A1 (en) | 2005-05-18 | 2006-11-23 | Aegera Therapeutics Inc. | Bir domain binding compounds |
| FR2894966B1 (fr) | 2005-12-20 | 2008-03-14 | Pierre Fabre Medicament Sa | Nouvelle forme cristalline de la vinflunine |
| BRPI0711591A2 (pt) | 2006-05-16 | 2011-11-16 | Aegera Therapeutics, Inc. | composto de ligação de domìnio bir da iap |
| WO2008033930A2 (en) * | 2006-09-12 | 2008-03-20 | Amr Technology, Inc. | Vinca derivatives |
| WO2008033935A2 (en) * | 2006-09-12 | 2008-03-20 | Amr Technology, Inc. | Vinorelbine derivatives |
| FR2905949B1 (fr) * | 2006-09-20 | 2008-11-21 | Pierre Fabre Medicament Sa | Derives fluores de catharanthine, leur preparation et leur utilisation comme precurseurs d'alcaloides dimeres de vinca |
| FR2910812B1 (fr) * | 2006-12-29 | 2009-03-20 | Pierre Fabre Medicament Sa | Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante |
| FR2912406B1 (fr) * | 2007-02-13 | 2009-05-08 | Pierre Fabre Medicament Sa | Sels cristalins anhydres de vinflunine, procede de preparation et utilisation en tant que medicament et moyen de purification de la vinflunine. |
| FR2918566B1 (fr) * | 2007-07-11 | 2009-10-09 | Pierre Fabre Medicament Sa | Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine. |
| FR2918567B1 (fr) * | 2007-07-11 | 2012-08-03 | Pf Medicament | Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine. |
| US20090076055A1 (en) * | 2007-09-14 | 2009-03-19 | Protia, Llc | Deuterium-enriched vinflunine |
| DE102010020994B4 (de) * | 2010-01-27 | 2022-01-27 | Interpane Entwicklungs-Und Beratungsgesellschaft Mbh | Verfahren zur Herstellung eines beschichteten Gegenstands mit Texturätzen |
| NZ602368A (en) | 2010-02-12 | 2014-10-31 | Pharmascience Inc | Iap bir domain binding compounds |
| JP5542972B2 (ja) * | 2010-02-22 | 2014-07-09 | ザ スクリプス リサーチ インスティテュート | Ｍｄｒがん細胞に対する強化された生物活性を提供する１０’−フッ素化ビンカアルカロイド |
| WO2026064520A1 (en) | 2024-09-19 | 2026-03-26 | Tesseract Medicines Us, Llc | Covalent-induced drug conjugates targeting kras and comprising a tubulin inhibitor payload |
| WO2026064527A1 (en) | 2024-09-19 | 2026-03-26 | Tesseract Medicines Us, Llc | Kras-targeting covalent-induced drug conjugates comprising a tubulin inhibitor payload |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2707988B1 (fr) * | 1993-07-21 | 1995-10-13 | Pf Medicament | Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant. |
| FR2761990B1 (fr) * | 1997-04-10 | 1999-06-25 | Pf Medicament | Derives halogenes antimitotiques d'alcaloides de vinca |
-
1997
- 1997-04-10 FR FR9704398A patent/FR2761990B1/fr not_active Expired - Lifetime
-
1998
- 1998-04-10 DE DE122010000054C patent/DE122010000054I1/de active Pending
- 1998-04-10 ES ES06124480T patent/ES2347878T3/es not_active Expired - Lifetime
- 1998-04-10 AT AT98920607T patent/ATE270297T1/de active
- 1998-04-10 DE DE69841766T patent/DE69841766D1/de not_active Expired - Lifetime
- 1998-04-10 CA CA2665949A patent/CA2665949C/fr not_active Expired - Lifetime
- 1998-04-10 WO PCT/FR1998/000730 patent/WO1998045301A1/fr not_active Ceased
- 1998-04-10 DK DK06124480.2T patent/DK1764368T3/da active
- 1998-04-10 PT PT06124480T patent/PT1764368E/pt unknown
- 1998-04-10 ES ES98920607T patent/ES2222588T3/es not_active Expired - Lifetime
- 1998-04-10 DK DK98920607T patent/DK0975640T3/da active
- 1998-04-10 EP EP98920607A patent/EP0975640B1/fr not_active Expired - Lifetime
- 1998-04-10 CA CA2455416A patent/CA2455416C/fr not_active Expired - Lifetime
- 1998-04-10 CA CA002286560A patent/CA2286560C/fr not_active Expired - Lifetime
- 1998-04-10 EP EP20030017052 patent/EP1357125A3/fr not_active Ceased
- 1998-04-10 EP EP06124480A patent/EP1764368B1/fr not_active Expired - Lifetime
- 1998-04-10 US US09/402,678 patent/US6127377A/en not_active Expired - Lifetime
- 1998-04-10 JP JP54247098A patent/JP4401440B2/ja not_active Expired - Lifetime
- 1998-04-10 BR BRPI9807944-1A patent/BR9807944B1/pt not_active IP Right Cessation
- 1998-04-10 DE DE69824840T patent/DE69824840T2/de not_active Expired - Lifetime
- 1998-04-10 AT AT06124480T patent/ATE473987T1/de active
- 1998-04-10 PT PT98920607T patent/PT975640E/pt unknown
- 1998-04-10 AU AU73408/98A patent/AU737549C/en not_active Expired
- 1998-04-10 BR BRPI9816177-6A patent/BR9816177B1/pt not_active IP Right Cessation
-
2004
- 2004-03-03 JP JP2004059502A patent/JP4307292B2/ja not_active Expired - Lifetime
-
2009
- 2009-03-11 JP JP2009058098A patent/JP2009167196A/ja active Pending
-
2010
- 2010-09-27 FR FR10C0045C patent/FR10C0045I2/fr active Active
- 2010-10-14 CY CY20101100917T patent/CY1111476T1/el unknown
- 2010-12-22 CY CY2010019C patent/CY2010019I2/el unknown
- 2010-12-22 LU LU91769C patent/LU91769I2/fr unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR10C0045I1 (enExample) | ||
| YU208687A (en) | Process for obtaining analog of rebecamicine | |
| SE7508332L (sv) | Sett att framstella 3-kinolin-karboxylsyraderivat och anvendning derav som lekemedel. | |
| ES2173316T3 (es) | Derivados de galantamina y proceso para su preparacion. | |
| ES8308889A1 (es) | Un procedimiento para la preparacion de nuevos derivados amonicos mono y bis-cuaternarios de 2 beta, 16 beta-diamino-5 alfa-androstanos. | |
| HUT40090A (en) | New process for production of derivatives of hh-1,2,4-triasole | |
| ATE44742T1 (de) | Verfahren zur herstellung von ergoline n-methyl- derivaten. | |
| NO159926C (no) | Fremgangsmaate for fremstilling av perfluoralkankarboksylsyrer. | |
| KR850004760A (ko) | 이미다조 퀴놀린 유도체의 제조방법 | |
| ES8300696A1 (es) | "procedimiento para preparar tiocarnitinas". | |
| JPS51113890A (en) | Method for preparing novel cephalosporins | |
| JPS57192341A (en) | Isoprenylamine derivative | |
| JPS54148750A (en) | Novel halogenoacetanilide derivative and its preparation | |
| UA6324A1 (uk) | Спосіб одержання похідних 6-фтор-1, дігідро-4-оксо-7-заміщений піперазінілхінолін-3-карбонової кислоти або їх фармацевтично прийнятних солей | |
| JPS5775996A (en) | Derivative of 4'''-aminoaclacinomycin a |